커피, 담배, 술이 파킨슨병에 미치는 영향

키워드

참고문헌 (53)

1. 설원기, "Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson’s disease", BMB Reports, 43(4), pp.233~244 (2010), 생화학분자생물학회
2. Gasser T, "Update on the genetics of Parkinson's disease", Mov Disord, 22(Suppl 17), pp.S343~S350 (2007)
3. Ascherio A, "The epidemiology of Parkinson's disease:risk factors and prevention", Lancet Neurol, 15, pp.1257~1272 (2016)
4. Wirdefeldt K, "Risk and protective factors for Parkinson's disease: a study in Swedish twins", Ann Neurol, 57, pp.27~33 (2005)
5. Fuxe K, "Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists", Med Biol, 52, pp.48~54 (1974)
6. Hong CT, "The effect of caffeine on the risk and progression of Parkinson's disease: a meta-analysis", Nutrients, 12, pp.1860~ (2020)
7. Hu G, "Coffee and tea consumption and the risk of Parkinson's disease", Mov Disord, 22, pp.2242~2248 (2007)
8. Socala K, "Neuroprotective effects of coffee bioactive compounds: a review", Int J Mol Sci, 22, pp.107~ (2020)
9. Ascherio A, "Caffeine, postmenopausal estrogen, and risk of Parkinson's disease", Neurology, 60, pp.790~795 (2003)
10. Xu K, "Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors", Neuroscience, 322, pp.129~137 (2016)
11. Chen JF, "The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease", Purinergic Signal, 16, pp.167~174 (2020)
12. Postuma RB, "Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): a randomized trial", Neurology, 89, pp.1795~1803 (2017)
13. Miyazaki I, "Effects of enteric environmental modification by coffee components on neurodegeneration in rotenone-treated mice", Cells, 8, pp.221~ (2019)
14. Colombo R, "An outlook on the role of decaffeinated coffee in neurodegenerative diseases", Crit Rev Food Sci Nutr, 60, pp.760~779 (2020)
15. Kim J, "Caffeinated coffee, decaffeinated coffee, and the phenolic phytochemical chlorogenic acid up-regulate NQO1 expression and prevent H2O2-induced apoptosis in primary cortical neurons", Neurochem Int, 60, pp.466~474 (2012)
16. Lee M, "Quercetin, not caffeine, is a major neuroprotective component in coffee", Neurobiol Aging, 46, pp.113~123 (2016)
17. Palacios N, "Caffeine and risk of Parkinson's disease in a large cohort of men and women", Mov Disord, 27, pp.1276~1282 (2012)
18. Crotty GF, "Targeting urate to reduce oxidative stress in Parkinson disease", Exp Neurol, 298, pp.210~224 (2017)
19. Bakshi R, "Associations of lower caffeine intake and plasma urate levels with idiopathic Parkinson's disease in the harvard biomarkers study", J Parkinsons Dis, 10, pp.505~510 (2020)
20. Gao X, "Diet, urate, and Parkinson's disease risk in men", Am J Epidemiol, 167, pp.831~838 (2008)
21. Park KY, "Effects of coffee consumption on serum uric acid: systematic review and meta-analysis", Semin Arthritis Rheum, 45, pp.580~586 (2016)
22. Gigante AF, "Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease", Neurol Sci, 39, pp.551~555 (2018)
23. Leite MR, "Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats", Exp Gerontol, 46, pp.309~315 (2011)
24. Malar DS, "Neuroprotective properties of green tea (Camellia sinensis) in Parkinson's disease: a review", Molecules, 25, pp.3926~ (2020)
25. Tan LC, "Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese health study", Am J Epidemiol, 167, pp.553~560 (2008)
26. Nefzger MD, "A retrospective study of smoking in Parkinson's disease", Am J Epidemiol, 88, pp.149~158 (1968)
27. Hernan MA, "Cigarette smoking and the incidence of Parkinson's disease in two prospective studies", Ann Neurol, 50, pp.780~786 (2001)
28. Ma C, "Nicotine from cigarette smoking and diet and Parkinson disease: a review", Transl Neurodegener, 6, pp.18~ (2017)
29. Mappin-Kasirer B, "Tobacco smoking and the risk of Parkinson disease: a 65-year follow-up of 30,000 male British doctors", Neurology, 94, pp.e2132~e2138 (2020)
30. O'Reilly EJ, "Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality", Am J Epidemiol, 169, pp.678~682 (2009)
31. Searles Nielsen S, "Environmental tobacco smoke and Parkinson's disease", Mov Disord, 27, pp.293~296 (2012)
32. O'Reilly EJ, "Smokeless tobacco use and the risk of Parkinson's disease mortality", Mov Disord, 20, pp.1383~1384 (2005)
33. Gatto NM, "Passive smoking and Parkinson's disease in California teachers", Parkinsonism Relat Disord, 45, pp.44~49 (2017)
34. Bono F, "Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation", Neurobiol Aging, 99, pp.65~78 (2021)
35. Villafane G, "High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study", Eur J Neurol, 25, pp.120~127 (2018)
36. Trinh K, "Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism", J Neurosci, 30, pp.5525~5532 (2010)
37. McCulloch CC, "Exploring gene-environment interactions in Parkinson's disease", Hum Genet, 123, pp.257~265 (2008)
38. Peng B, "Role of alcohol drinking in alzheimer's disease, parkinson's disease, and amyotrophic lateral sclerosis", Int J Mol Sci, 21, pp.2316~ (2020)
39. Kamal H, "Alcohol Use disorder, neurodegeneration, alzheimer's and Parkinson's disease: interplay between oxidative stress, neuroimmune response and excitotoxicity", Front Cell Neurosci, 14, pp.282~ (2020)
40. Liu R, "Alcohol consumption, types of alcohol, and parkinson's disease", PLoS One, 8, pp.e66452~ (2013)
41. Kim IY, "Alcohol intake and Parkinson's disease risk in the million women study", Mov Disord, 35, pp.443~449 (2020)
42. Karkhanis AN, "Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens", Drug Alcohol Depend, 150, pp.24~30 (2015)
43. Vaglini F, "Acetaldehyde and parkinsonism: role of CYP450 2E1", Front Behav Neurosci, 7, pp.71~ (2013)
44. Cahill CM, "Alpha-Synuclein in alcohol use disorder, connections with Parkinson's disease and potential therapeutic role of 5' untranslated region-directed small molecules", Biomolecules, 10, pp.1465~ (2020)
45. Cho BH, "Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson's disease", BMC Neurol, 19, pp.194~ (2019)
46. Lee Y, "Does smoking impact dopamine neuronal loss in de novo Parkinson disease?", Ann Neurol, 82, pp.850~854 (2017)
47. 김률, "Smoking Cessation, Weight Change, and Risk of Parkinson’s Disease: Analysis of National Cohort Data", Journal of Clinical Neurology, 16(3), pp.455~460 (2020), 대한신경과학회
48. Kang JH, "Effects of smoking on patients with Parkinson’s disease", J Korean Neurol Assoc, 18, pp.394~401 (2000)
49. van der Mark M, "A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking", PLoS One, 9, pp.e95297~ (2014)
50. Braak H, "Staging of brain pathology related to sporadic Parkinson's disease", Neurobiol Aging, 24, pp.197~211 (2003)
51. Shannon KM, "Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases", Mov Disord, 27, pp.716~719 (2012)
52. Derkinderen P, "Gut feelings about smoking and coffee in Parkinson's disease", Mov Disord, 29, pp.976~979 (2014)
53. Fratiglioni L, "Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies", Behav Brain Res, 113, pp.117~120 (2000)

관련 논문AI추천